Table 3.

Prevalence of dysmetabolic diseases and biochemical abnormalities in the 677 patients diagnosed with fatty liver n (%)

	Patients examined	Positive patients
Increased ALT and/or AST levels	676	199 (29.4)
Hypertriglyceridemia	635	197 (31.0)
Mixed type hyperlipidemia	635	135 (21.3)
Hypercholesterolemia	635	92 (14.5)
Hyperglycemia	640	116 (18.1)
Hypertension	636	102 (16.0)
Gallstone	677	97 (14.4)
Hyperuricemia	627	87 (13.9)
HBsAg	506	39 (7.7)
Increased Scr levels	507	3 (0.6)

HBsAg: Hepatitis B surface antigen; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; Scr: Serum creatinine.